Corteva, Inc. (NYSE:CTVA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Corteva, Inc. (NYSE:CTVA) has been assigned an average rating of “Moderate Buy” from the twenty-two ratings firms that are covering the stock, MarketBeat.com reports. Nine analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $88.9048.

Several brokerages have commented on CTVA. UBS Group decreased their price objective on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a report on Tuesday, June 9th. Royal Bank Of Canada boosted their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Berenberg Bank increased their price target on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Morgan Stanley raised their price objective on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Corteva from $90.00 to $100.00 in a report on Monday, May 11th.

Corteva Trading Up 2.3%

NYSE CTVA traded up $1.97 on Monday, hitting $85.83. The company’s stock had a trading volume of 2,181,753 shares, compared to its average volume of 4,151,679. Corteva has a 52-week low of $60.53 and a 52-week high of $87.69. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company’s 50-day simple moving average is $80.42 and its 200 day simple moving average is $77.54. The firm has a market cap of $57.40 billion, a P/E ratio of 50.49, a PEG ratio of 2.57 and a beta of 0.56.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s payout ratio is currently 42.35%.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC increased its stake in shares of Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares in the last quarter. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth about $25,000. Westfuller Advisors LLC grew its holdings in Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after purchasing an additional 387 shares during the period. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva during the fourth quarter valued at approximately $27,000. Finally, Bank of Jackson Hole Trust purchased a new position in shares of Corteva during the fourth quarter valued at approximately $28,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.